» Articles » PMID: 37452431

Pathogenesis of MiR-155 on Nonmodifiable and Modifiable Risk Factors in Alzheimer's Disease

Overview
Date 2023 Jul 14
PMID 37452431
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) is a common age-related neurodegenerative disease in the central nervous system and is the primary cause of dementia. It is clinically characterized by the memory impairment, aphasia, apraxia, agnosia, visuospatial and executive dysfunction, behavioral changes, and so on. Incidence of this disease was bound up with age, genetic factors, cardiovascular and cerebrovascular dysfunction, and other basic diseases, but the exact etiology has not been clarified. MicroRNAs (miRNAs) are small endogenous non-coding RNAs that were involved in the regulation of post-transcriptional gene expression. miRNAs have been extensively studied as noninvasive potential biomarkers for disease due to their relative stability in bodily fluids. In addition, they play a significant role in the physiological and pathological processes of various neurological disorders, including stroke, AD, and Parkinson's disease. MiR-155, as an important pro-inflammatory mediator of neuroinflammation, was reported to participate in the progression of β-amyloid peptide and tau via regulating immunity and inflammation. In this review, we put emphasis on the effects of miR-155 on AD and explore the underlying biological mechanisms which could provide a novel approach for diagnosis and treatment of AD.

Citing Articles

The role of miR-155 in cardiovascular diseases: Potential diagnostic and therapeutic targets.

Zhang R, Wang W, Li J, Li R, Zhang J, Wu Y Int J Cardiol Cardiovasc Risk Prev. 2025; 24:200355.

PMID: 39760132 PMC: 11699627. DOI: 10.1016/j.ijcrp.2024.200355.


The Yin and Yang of Microglia-Derived Extracellular Vesicles in CNS Injury and Diseases.

Ghosh M, Pearse D Cells. 2024; 13(22).

PMID: 39594583 PMC: 11592485. DOI: 10.3390/cells13221834.


MiR-155-5p regulates autophagy and apoptosis of glioma cells through RICTOR.

Guo Z, Tian J, Wang Y, Jiang L, Chen Y, Dai H Transl Cancer Res. 2024; 13(10):5509-5521.

PMID: 39525027 PMC: 11543026. DOI: 10.21037/tcr-24-543.


Role of Post-Transcriptional Regulation in Learning and Memory in Mammals.

Di Liegro C, Schiera G, Schiro G, Di Liegro I Genes (Basel). 2024; 15(3).

PMID: 38540396 PMC: 10970538. DOI: 10.3390/genes15030337.


Mechanisms of 3-Hydroxyl 3-Methylglutaryl CoA Reductase in Alzheimer's Disease.

Zhou X, Wu X, Wang R, Han L, Li H, Zhao W Int J Mol Sci. 2024; 25(1).

PMID: 38203341 PMC: 10778631. DOI: 10.3390/ijms25010170.


References
1.
Nuovo G, Tili E, Awad H, Michaille J . [Roles of miR-155 microRNA in dementia associated with Down's syndrome]. Med Sci (Paris). 2018; 34(11):922-924. DOI: 10.1051/medsci/2018231. View

2.
Lu T, Rothenberg M . MicroRNA. J Allergy Clin Immunol. 2017; 141(4):1202-1207. PMC: 5889965. DOI: 10.1016/j.jaci.2017.08.034. View

3.
Saiz-Vazquez O, Gracia-Garcia P, Ubillos-Landa S, Puente-Martinez A, Casado-Yusta S, Olaya B . Depression as a Risk Factor for Alzheimer's Disease: A Systematic Review of Longitudinal Meta-Analyses. J Clin Med. 2021; 10(9). PMC: 8122638. DOI: 10.3390/jcm10091809. View

4.
Sierksma A, Lu A, Salta E, Vanden Eynden E, Callaerts-Vegh Z, DHooge R . Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology. Mol Neurodegener. 2018; 13(1):54. PMC: 6186090. DOI: 10.1186/s13024-018-0285-1. View

5.
Blennow K, Mattsson N, Scholl M, Hansson O, Zetterberg H . Amyloid biomarkers in Alzheimer's disease. Trends Pharmacol Sci. 2015; 36(5):297-309. DOI: 10.1016/j.tips.2015.03.002. View